Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 2 results out of 2
Data Insights
RD-07 by Nanjing Bioheng Biotech for Pancreatic Cancer: Likelihood of Approval
RD-07 is under clinical development by Nanjing Bioheng Biotech and currently in Phase I for Pancreatic Cancer. According to GlobalData,...
Data Insights
RD-07 by Nanjing Bioheng Biotech for Adenocarcinoma Of The Gastroesophageal Junction: Likelihood of Approval
RD-07 is under clinical development by Nanjing Bioheng Biotech and currently in Phase I for Adenocarcinoma Of The Gastroesophageal Junction....